STK11, serine/threonine kinase 11, 6794

N. diseases: 372; N. variants: 145
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.550 AlteredExpression disease BEFREE In this study, both the mRNA and protein expression levels of LKB1, p53, and p21 decreased in OCCs following transfection with a miR-17 expression plasmid. 25510663 2015
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.550 Biomarker disease BEFREE Results of the present study suggested that combined therapy with eukaryotic co-expression of the plasmid‑carrying STAT3-specific siRNA and LKB1 is a novel and efficient treatment strategy for human ovarian cancer. 25420630 2015
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.550 Biomarker disease BEFREE Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer. 24170201 2014
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.550 Biomarker disease BEFREE Recent studies showed that loss of function of LKB1 is associated with sporadic forms of lung, pancreatic, and ovarian cancer. 17761947 2007
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.550 GeneticVariation disease BEFREE Our results suggest that mutations of the STK11 gene may play a limited role in the development of ovarian carcinomas. 10429654 1999
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.550 GeneticVariation disease UNIPROT
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.550 GenomicAlterations disease CGI
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.550 CausalMutation disease CGI